Jonathan Pan

A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia

M. Kasner, D. Hangauer, E. Ritchie, 2022, Investigational New Drugs.

Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and Beyond.

L. Wilde, Jonathan Pan, 2019, Clinical lymphoma, myeloma & leukemia.

Staphylococcus aureus Skin Infections

Jonathan Pan, Julie E. Reznicek, 2020 .

Nasopharyngeal Cancer in Non-Endemic Areas: Impact of Treatment Intensity within a Large Retrospective Multicenter Cohort

A. Argiris, A. Trama, P. Franco, 2021, SSRN Electronic Journal.

Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome

D. Altman, L. Wilde, Jonathan Pan, 2020, Frontiers in Oncology.

Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters.

P. Porcu, M. Kasner, T. Klumpp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

P. Porcu, U. Martinez-outschoorn, N. Flomenberg, 2020, Leukemia & lymphoma.

Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort.

A. Argiris, I. Garassino, A. Trama, 2021, European journal of cancer.